These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38050231)

  • 1. Anti-Nasopharyngeal carcinoma mechanism of sanguinarine based on network pharmacology and molecular docking.
    Fan JY; Liu J; Zhang WQ; Lin T; Hu XR; Zhou FL; Tang L; He YC; Shi HJ
    Medicine (Baltimore); 2023 Dec; 102(48):e36477. PubMed ID: 38050231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Luteolin Isolated from
    Xiong Y; Zhong W; Liu J; Cheng B; Fan J; Zhou F; He L; Tian D; He Y
    Biomed Res Int; 2022; 2022():9740066. PubMed ID: 36588531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the Molecular Mechanism of
    Xu R; Yang X; Tao Y; Luo W; Xiong Y; He L; Zhou F; He Y
    J Healthc Eng; 2022; 2022():6277139. PubMed ID: 35463684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
    Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
    J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the pharmacological mechanisms of Biyan Qingdu Granula in the treatment after nasopharyngeal carcinoma radiotherapy based on UPLC/Q-TOF MS, network pharmacology and molecular docking.
    Yi B; Lv F; Zhang N; Lin J; Xu K; Li C; Li P; Zhao M
    J Pharm Biomed Anal; 2024 Feb; 239():115830. PubMed ID: 38096633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Network pharmacology, molecular docking and experimental study of CEP in nasopharyngeal carcinoma.
    Yang J; Qin L; Zhou S; Li J; Tu Y; Mo M; Liu X; Huang J; Qin X; Jiao A; Wei W; Yang P
    J Ethnopharmacol; 2024 Apr; 323():117667. PubMed ID: 38159821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration of Network Pharmacology and Molecular Docking Technology Reveals the Mechanism of the Therapeutic Effect of Xixin Decoction on Alzheimer's Disease.
    Zhang Z; Xu J; Ma S; Lin N; Hou M; Wei M; Li T; Shi J
    Comb Chem High Throughput Screen; 2022; 25(10):1785-1804. PubMed ID: 35616676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Network pharmacology-based prediction and validation of the active ingredients and potential mechanisms of the Huangxiong formula for treating ischemic stroke.
    Zhao S; Zhang P; Yan Y; Xu W; Li J; Wang L; Wang N; Huang Y
    J Ethnopharmacol; 2023 Aug; 312():116507. PubMed ID: 37080367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Network pharmacology and experimental verification of the potential mechanism of Er-Xian decoction in aplastic anemia.
    Ye M; Liu G; Yang Y; Yang H; Ren J; Chen W; Gao Z
    Sci Rep; 2023 Oct; 13(1):17385. PubMed ID: 37833363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Assessment of
    Shi H; Liu J; Fan J; He L; Wang X; Tang F; Tian D; He Y
    Evid Based Complement Alternat Med; 2022; 2022():1988378. PubMed ID: 35178099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploration of the Molecular Mechanism of Polygonati Rhizoma in the Treatment of Osteoporosis Based on Network Pharmacology and Molecular Docking.
    Zhao J; Lin F; Liang G; Han Y; Xu N; Pan J; Luo M; Yang W; Zeng L
    Front Endocrinol (Lausanne); 2021; 12():815891. PubMed ID: 35069454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of the potential mechanism of compound gingerol against liver cancer based on network pharmacology and experimental verification.
    Su M; Wang X; Cao G; Sun L; Ho RJY; Han Y; Hong Y; Wu D
    J Pharm Pharmacol; 2022 Jun; 74(6):869-886. PubMed ID: 35429380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of Bazhen decoction in the treatment of colorectal cancer based on network pharmacology, molecular docking, and experimental validation.
    Lu S; Sun X; Zhou Z; Tang H; Xiao R; Lv Q; Wang B; Qu J; Yu J; Sun F; Deng Z; Tian Y; Li C; Yang Z; Yang P; Rao B
    Front Immunol; 2023; 14():1235575. PubMed ID: 37799727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the mechanism and experimental validation of Fuzi Lizhong Tang in treating gastric cancer based on network pharmacology and molecular docking.
    Zhang FY; Guo SC
    Eur Rev Med Pharmacol Sci; 2023 Oct; 27(19):9192-9204. PubMed ID: 37843333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanism of Bupleurum scorzonerifolium and Paeonia lactiflora herbal pair against liver cancer: an exploration based on UPLC-Q-TOF-MS combined with network pharmacology].
    Zou X; Sui Y; Tang XY; Zhang R; Shu Q; Gong T; Wu S; Sun ZW; Li WL; Qu ZY
    Zhongguo Zhong Yao Za Zhi; 2022 Jul; 47(13):3597-3608. PubMed ID: 35850814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploration of the Effect and Potential Mechanism of Echinacoside Against Endometrial Cancer Based on Network Pharmacology and in vitro Experimental Verification.
    Shu W; Wang Z; Zhao R; Shi R; Zhang J; Zhang W; Wang H
    Drug Des Devel Ther; 2022; 16():1847-1863. PubMed ID: 35734366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol activates MAPK/ERK pathway to regulate oestrogen metabolism in type I endometrial cancer.
    Wang Q; Zhou JY; Liu L; Yin ZY; Li YY; Wang M; Zhang JB; Lu H; Zhou XY; Zhang B
    BMC Complement Med Ther; 2024 Jun; 24(1):227. PubMed ID: 38862934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network-based Pharmacology and
    Long X; Chen L; Yang J; Dong T; Cheng Q; Wang W; Zou Y; Su Y; Dai W; Chen B; Zhou X
    Anticancer Agents Med Chem; 2023; 23(7):847-857. PubMed ID: 36305128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
    Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
    J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Network pharmacology identification and in Vivo validation of key pharmacological pathways of Phyllanthus reticulatus (Euphorbiaceae) leaf extract in liver cancer treatment.
    Tang Y; Sun L; Wei J; Sun C; Gan C; Xie X; Liang C; Peng C; Wu H; Zheng Z; Pan Z; Huang Y
    J Ethnopharmacol; 2022 Oct; 297():115479. PubMed ID: 35777610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.